{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:30:34Z","timestamp":1784140234464,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology of Japan","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ministry of Health, Labour, and Welfare of Japan, and Keio Gijuku Academic Development Fund"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jdsjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jdermsci.2016.12.007","type":"journal-article","created":{"date-parts":[[2016,12,6]],"date-time":"2016-12-06T17:18:52Z","timestamp":1481044732000},"page":"208-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Validation of chemiluminescent enzyme immunoassay in detection of autoantibodies in pemphigus and pemphigoid"],"prefix":"10.1016","volume":"85","author":[{"given":"Yumi","family":"Fujio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Hashiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Wakui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Amagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yamagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2016.12.007_bib0005","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.4049\/jimmunol.159.4.2010","article-title":"Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins","volume":"159","author":"Ishii","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2016.12.007_bib0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0190-9622(99)70183-0","article-title":"The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile","volume":"40","author":"Amagai","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.12.007_bib0015","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1365-2133.2004.06245.x","article-title":"Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients","volume":"151","author":"Mariotti","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.12.007_bib0020","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0923-1811(02)00109-3","article-title":"BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid","volume":"30","author":"Kobayashi","year":"2002","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2016.12.007_bib0025","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1365-2133.1999.02752.x","article-title":"Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus","volume":"140","author":"Amagai","year":"1999","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.12.007_bib0030","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archdermatol.2009.9","article-title":"ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus","volume":"145","author":"Abasq","year":"2009","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.12.007_bib0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/ced.12187","article-title":"Comparison of desmoglein 1 and 3 enzyme-linked immunosorbent assay and direct immunofluorescence for evaluation of immunological remission in pemphigus vulgaris","volume":"39","author":"Daneshpazhooh","year":"2014","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.12.007_bib0040","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1468-3083.2011.04428.x","article-title":"Correlation of antibodies against desmogleins 1 and 3 with indirect immunofluorescence and disease status in a Greek population with pemphigus vulgaris","volume":"27","author":"Avgerinou","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jdermsci.2016.12.007_bib0045","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1172\/JCI5252","article-title":"Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris","volume":"103","author":"Mahoney","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jdermsci.2016.12.007_bib0050","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jdermsci.2004.10.007","article-title":"Correlation of clinical severity and ELISA indices for the NC16A domain of BP180 measured using BP180 ELISA kit in bullous pemphigoid","volume":"37","author":"Tsuji-Abe","year":"2005","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2016.12.007_bib0055","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/ced.12510","article-title":"Diagnostic accuracy of BP180 NC16a and BP230-C3 ELISA in serum and saliva of patients with bullous pemphigoid","volume":"40","author":"Esmaili","year":"2015","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.12.007_bib0060","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-4632.2008.03473.x","article-title":"Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid","volume":"47","author":"Feng","year":"2008","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.12.007_bib0065","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1468-3083.2008.02715.x","article-title":"Anti-desmoglein IgG autoantibodies in patients with pemphigus in remission","volume":"22","author":"Kwon","year":"2008","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jdermsci.2016.12.007_bib0070","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2340\/00015555-2023","article-title":"Autoantibody levels and clinical disease severity in patients with pemphigus: comparison of aggregated anti-desmoglein ELISA values and indirect immunofluorescence titres","volume":"95","author":"Weiss","year":"2015","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.jdermsci.2016.12.007_bib0075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1684\/ejd.2012.1901","article-title":"Evaluation of commercially available ELISA assays as a tool for monitoring and managing pemphigus patients: a prospective study","volume":"23","author":"Bracke","year":"2013","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.12.007_bib0080","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archderm.136.2.174","article-title":"Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid","volume":"136","author":"Schmidt","year":"2000","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.12.007_bib0085","first-page":"174","article-title":"Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid","volume":"136","author":"Feng","year":"2000","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.12.007_bib0090","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.1365-2133.2002.04838.x","article-title":"Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3","volume":"147","author":"Cheng","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.12.007_bib0095","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cca.2009.09.032","article-title":"Comparison of chemiluminescence enzyme immunoassay (CLEIA) with ELISA for the determination of anti-cyclic citrullinated peptide antibodies","volume":"411","author":"Tanaka","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jdermsci.2016.12.007_bib0100","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jpha.2011.10.001","article-title":"Comparison of chemiluminescence enzyme immunoassay based on magnetic microparticles with traditional colorimetric ELISA for the detection of serum \u03b1-fetoprotein","volume":"2","author":"Zhang","year":"2012","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jdermsci.2016.12.007_bib0105","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1001\/jamadermatol.2013.8175","article-title":"Pemphigus disease activity measurements: pemphigus disease area index, autoimmune bullous skin disorder intensity score, and pemphigus vulgaris activity score","volume":"150","author":"Rahbar","year":"2014","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.jdermsci.2016.12.007_bib0110","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/1346-8138.12649","article-title":"Grading criteria for disease severity by pemphigus disease area index","volume":"41","author":"Shimizu","year":"2014","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.12.007_bib0115","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1038\/jid.2009.72","article-title":"Reliability and convergent validity of two outcome instruments for pemphigus","volume":"129","author":"Rosenbach","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.12.007_bib0120","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaad.2011.06.032","article-title":"Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts","volume":"66","author":"Murrell","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.12.007_bib0125","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000362717","article-title":"Assessment of bullous pemphigoid disease area index during treatment: a prospective study of 30 patients","volume":"229","author":"L\u00e9vy-Sitbon","year":"2014","journal-title":"Dermatology"}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181116310210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181116310210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T06:00:48Z","timestamp":1692597648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181116310210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0923181116310210"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2016.12.007","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of chemiluminescent enzyme immunoassay in detection of autoantibodies in pemphigus and pemphigoid","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2016.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}